Amgen, Inc. (AMGN)
329.89
-10.27
(-3.02%)
USD |
NASDAQ |
Dec 05, 16:00
329.60
-0.29
(-0.09%)
After-Hours: 20:00
Amgen Shareholders Equity (Quarterly): 9.619B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.21B |
| Gilead Sciences, Inc. | 21.54B |
| Johnson & Johnson | 79.28B |
| Eli Lilly & Co. | 23.79B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.14B |
| Total Liabilities (Quarterly) | 80.52B |
| Debt to Equity Ratio | 5.675 |
| Current Ratio | 1.280 |
| Net Debt Paydown Yield | 1.06% |